Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theragene and radiation therapy in pancreatic cancer
NCT04739046Phase 2Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Feb 2021
- Primary completion
- Aug 2022
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of ad5-ycd/muttksr39rep-adp in pancreatic cancer (PC), sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
ad5-ycd/muttksr39rep-adp
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04739046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04739046.